drugset / Trial / NCT06139380

Intranasal Ketamine Effectiveness in Reducing Intramuscular Injection Pain Before Sedation Among Children

NCT06139380 ↗

Phase 4 Completed 84 enrolled Tehran University of Medical Sciences
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Hypothesis: Intranasal administration of ketamine would reduce the intramuscular pain of ketamine injection in children who undergo procedural sedation and analgesia in the emergency department.

Timeline

Start
2023-12-02
Primary completion
2024-04-28
Completion
2024-05-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule — Intranasal

Indications

No indication recorded.